Study: Halegoua-DeMarzio 2023, American Journal of Medicine

Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]

Citation

Halegoua-DeMarzio D, Navarro V, Ahmad J, Avula B et al (2023). American Journal of Medicine. PubMed id 36252717.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Turmeric and curcumin supplements Tier B moderate

    B Ten people in the US Drug-Induced Liver Injury Network with turmeric-associated liver injury (eight women; nine White; median age 56) (n=10)

    Case series with chemical analysis of products and HLA genetic typing.

    Five were hospitalised and one died of acute liver failure. Injury began 1 to 4 months after starting, mostly hepatocellular, and turmeric was confirmed in all seven products tested (three also contained black pepper extract). Seven carried HLA-B*35:01 (allele frequency 0.45 against 0.06 to 0.07 in controls). The authors say turmeric liver injury appears to be increasing.

    As recorded in this card: Halegoua-DeMarzio D, Navarro V, Ahmad J, Avula B et al (2023), American Journal of Medicine, [primary]

    Note: A small case series, mostly White participants, so it says nothing about how common the HLA type is in other populations. HLA-B*35:01 is the measured variable.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.